vismodegib
Showing 1 - 25 of 58
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, PARP Inhibitor Trial in Pittsburgh
Not yet recruiting
- Platinum-Resistant Fallopian Tube Carcinoma
- +3 more
- Vismodegib
- Atezolizumab
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Sep 8, 2022
Clear Cell Chondrosarcoma, Dedifferentiated Chondrosarcoma, Locally Advanced Chondrosarcoma Trial in France (Laboratory
Active, not recruiting
- Clear Cell Chondrosarcoma
- +6 more
- Laboratory Biomarker Analysis
- +2 more
-
Bordeaux, France
- +5 more
Sep 20, 2022
Carcinoma, Basal Cell Trial in Ann Arbor (Vismodegib)
Completed
- Carcinoma, Basal Cell
- Vismodegib
-
Ann Arbor, MichiganUniversity of Michigan Hospital
Sep 29, 2021
Basal Cell Carcinoma, Radiotherapy; Complications Trial (radiation, other, drug)
Not yet recruiting
- Basal Cell Carcinoma
- Radiotherapy; Complications
- Radiotherapy
- +2 more
- (no location specified)
Sep 30, 2022
Basal Cell Carcinoma Trial in Germany (Vismodegib)
Completed
- Basal Cell Carcinoma
- Vismodegib
-
Gera, Thuringia, Germany
- +11 more
Feb 10, 2022
Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma, Metastatic Basal Cell Carcinoma Trial in Netherlands (Vismodegib,
Recruiting
- Basal Cell Carcinoma
- +10 more
- Vismodegib
- Sonidegib
-
Nijmegen, Gelderland, Netherlands
- +7 more
Jul 14, 2022
Locally Advanced Basal Cell Carcinoma, Skin Cancer, Cutaneous Malignancy Trial in San Francisco, New York (Vismodegib, Radiation
Completed
- Locally Advanced Basal Cell Carcinoma
- +2 more
- Vismodegib
- Radiation therapy
-
San Francisco, California
- +1 more
Apr 7, 2021
Chronic GVHD Trial in Ann Arbor, Salt Lake City (Laboratory Biomarker Analysis, Vismodegib)
Terminated
- Chronic Graft Versus Host Disease
- Laboratory Biomarker Analysis
- Vismodegib
-
Ann Arbor, Michigan
- +1 more
Jun 22, 2021
Keratocystic Odontogenic Tumor Trial in New York (vismodegib)
Completed
- Keratocystic Odontogenic Tumor
- vismodegib
-
New York, New YorkNYU Bluestone Center For Cllinical Research
Feb 1, 2021
Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)
Recruiting
- Advanced Cancer
- Solid Tumor
- Alectinib
- +13 more
-
Helsinki, Uusimaa, Finland
- +2 more
Jun 8, 2022
Basal Cell Nevus Syndrome, Gorlin's Syndrome Trial in Oakland, New York (Vismodegib, Aminolevulinic acid %20 topical solution)
Completed
- Basal Cell Nevus Syndrome
- Gorlin's Syndrome
- Vismodegib
- Aminolevulinic acid %20 topical solution
-
Oakland, California
- +2 more
Oct 8, 2020
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Olaparib
- +13 more
-
Edmonton, Alberta, Canada
- +9 more
Jan 9, 2023
Vismodegib (Erivedge®) in Advanced Basal Cell Carcinoma (BCC)
Completed
- Basal Cell Carcinoma
- Vismodegib
-
Göteborg, Sweden
- +3 more
Oct 8, 2020
Carcinoma, Basal Cell Trial in Rozzano (Vismodegib, Radiotherapy)
Terminated
- Carcinoma, Basal Cell
- Vismodegib
- Radiotherapy
-
Rozzano, Mi, ItalyIstituto Clinico humanitas
Jan 27, 2020
Basal Cell Nevus Syndrome Trial (Vismodegib, Nivolumab, Ipilimumab)
Withdrawn
- Basal Cell Nevus Syndrome
- Vismodegib
- +2 more
- (no location specified)
Dec 16, 2019
Basal Cell Carcinomas Trial in Tucson (Vismodegib, Placebo)
Terminated
- Basal Cell Carcinomas
- Vismodegib
- Placebo
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Jul 30, 2019
Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)
Recruiting
- Cancer
- +3 more
- Panitumumab
- +32 more
-
Amersfoort, Utrecht, Netherlands
- +34 more
Oct 26, 2021
Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation Trial in United States (Vismodegib, FAK Inhibitor GSK2256098,
Recruiting
- Intracranial Meningioma
- +2 more
- Vismodegib
- +3 more
-
Birmingham, Alabama
- +707 more
Sep 25, 2022
Vismodegib in Locally Advanced Basal Cell Carcinoma
Completed
- Carcinoma, Basal Cell
- Vismodegib
-
Frankfurt, GermanyKlinik Johann Wolfgang von Goethe Uni; Klinik für Dermatologie,
May 10, 2019
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- vismodegib
- +6 more
-
Scottsdale, Arizona
- +2 more
Apr 4, 2019
Skin Basal Cell Carcinoma Trial in Palo Alto (Pembrolizumab, Vismodegib)
Completed
- Skin Basal Cell Carcinoma
- Pembrolizumab
- Vismodegib
-
Palo Alto, CaliforniaStanford University School of Medicine
Mar 6, 2019
Histologically Confirmed Medulloblastoma, Activation of the Sonic Hedgehog (SHH) Pathway Trial in Worldwide (vismodegib,
Terminated
- Histologically Confirmed Medulloblastoma
- Activation of the Sonic Hedgehog (SHH) Pathway
- vismodegib
- Temozolomide
-
Marseille, Bouches Du Rhône, France
- +14 more
May 20, 2019